{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN7no4wLDA","lastupdate":"2024-05-09T00:00:00.000Z","update_date":"2024-05-09T00:00:00.000Z","lastModified":"Feb 16, 2025","active":1,"confidence_score":90,"confidence_score_reason":"video or image, markets, not claimed","urlname":"btg-bio-technology-general","minimal_profile":null,"status":"Acquired","fullstatus":"Acquired by Ferring Pharmaceuticals on Jan, 2005","acquired":1,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$z9OMjnaNOrlNYAgvJuOia25w4MpmHXqjhXNma3J7hQvODZ9xl7qBle.jpeg","name":"BTG","oneliner":"Genetically Engineered Drugs","registrar":"510861370","website":"https://www.btgil.com","careerspage":"","founded_month":9,"founded_year":1980,"formernames":[],"sociallinks":{"twitter":"","youtube":"","facebook":"https://www.facebook.com/btgil","linkedin":"https://www.linkedin.com/company/151809","instagram":""},"social":["https://www.facebook.com/btgil","https://www.linkedin.com/company/151809"],"flattenedsociallinks":"https://www.facebook.com/btgil|https://www.linkedin.com/company/151809","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":null,"employees":"201-500","employees_exact":348,"patent":0,"raised":26930000,"stage":"Acquired","public_stage":"Acquired","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":["B.T.G","Bio-Technology General"],"about":"Bio-Technology General Israel (BTG) is an integrated biopharmaceutical services company that develops and manufactures healthcare products derived from genetic engineering and biotechnology processes.\r\n\r\nBTGs Biolon, first introduced in 1993, is an injectable system containing 1% fermentation-derived sodium hyaluronate (NaHA) used as a viscoelastic aid in cataract and other ophthalmic surgeries.\r\n\r\nEuflexxa is a treatment to help relieve knee pain due to osteoarthritis (OA). It is used by thousands of people to help manage OA knee pain and stay active. Containing 1% fermentation-derived sodium hyaluronate, Euflexxa is intended for intra-articular injection into the knee.\r\n\r\nDeveloped in the 1980s, BTGs recombinant human growth hormone (somatropin for injection or hGH) first gained regulatory approval in 1988. It is identical to natural human growth hormone synthesized by the pituitary gland, and is used to treat Turner syndrome and growth hormone deficiency in children.\r\n\r\nBTG is a wholly owned subsidiary of Ferring Pharmaceuticals.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"+97288612020","country":null,"address":{"israeli":[{"id":"5ad5e5c8-41d1-4dd7-bfd3-c223dbeaf3f7","city":"Be'er Tuvia","type":null,"address":"Be'er Tuvia, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":null},"headquarter_address":null,"district":"South District","news":[{"id":"YpATKi4PzzYAzJO3LrJVlghbn6VSc6kFaX1IU66Xy0XOzjoa01shjY","date":"Sep 11, 2023","link":"https://www.israelhayom.co.il/you-may-find-interesting/article/14597536","source":"www.israelhayom.co.il","visible":1,"analysis":null,"sentiment":null,"analysisId":"gcK5p563AB1MkcTWZwcjHWGJ4S6bswWvLDLbEiiMuNH31GA9t2icjl","news_summary":"BTG's vision: The State of Israel is a world leader in biological GMP production","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"none"},{"id":"pjWtTnhJFQLUt7jAitPR23lZ53f8rIDknl0OlkBwwsCUjSM93pZgon","date":"Jan 12, 2022","link":"https://www.themarker.com/labels/technologies/btg/2022-01-12/ty-article-labels/0000017f-f890-d318-afff-fbf31bf10000","source":"www.themarker.com","visible":1,"analysis":{"tags":"Partnership, Biotech","company":"Ferring-BTG","layoffs":"N/A","summary":"Ferring-BTG, a subsidiary of Swiss pharmaceutical company Ferring Pharmaceuticals, is helping young Israeli biotech companies transition from research to clinical trials. The company has been investing heavily in the microbiome and genetic editing fields, and is also supporting smaller companies born in academia and hospitals. Ferring-BTG has been involved in the fight against COVID-19, supporting startups in bringing vaccines and drugs against the virus to clinical trials. The company is now exploring additional partnerships, not necessarily related to vaccines/drugs for COVID-19.","partners":"Israeli biotech startups","customers":"N/A","investors":"N/A","confidence":8,"key_topics":["Biotech","Partnership","Clinical Trials","Investment","Expansion"],"date_of_event":"N/A","valuation_amount":"N/A","impact_on_company":"growth-positive","investment_amount":"N/A","structured_issues":"Partners, Expand","acquisition_amount":"N/A","structuredIssuesShow":"#Partners, Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"XjiHXmstbWcapa3t1Yqsw59x96DA53ngRLLHFoOL18QJYOvcqJUUub","news_summary":"With 40 years of experience in the field of drug development and production, a general biotechnology company - Ferring Pharmaceuticals helps start-up companies in the field of biotech to reach the stage of clinical trials - without leaving the borders of the country","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"e73882fe-8968-4e8c-b127-04b0f0efed94","date":"Oct 1, 2019","link":"https://www.jpost.com/Jpost-Tech/Biotechnology-General-opens-production-line-to-boost-manufacturing-capacity-603348","source":"www.jpost.com","visible":1,"analysis":{"tags":"pharmaceuticals, genetic engineering","company":"Biotechnology General (BTG)","layoffs":null,"summary":"Biotechnology General (BTG), an Israeli-based company, has launched a production line that increases the capacity of mammalian drug production. The investment for the production line was $17 million. Ferring Pharmaceuticals, BTGs parent company, provided the investment. The inauguration of the production line was attended by Ferring President Per Falk, who highlighted the importance of BTG in Ferrings goal to be a world leader in reproductive medicine and maternal health. BTG is the oldest biological pharmaceutical company in Israel and has expanded over the years to become significant in the production of genetically engineered drugs. The new production line strengthens BTGs capacity for future growth and development.","partners":["Ferring Pharmaceuticals"],"customers":null,"investors":"Ferring Pharmaceuticals","confidence":9,"key_topics":["production line","investment","genetic engineering","Ferring Pharmaceuticals","expansion"],"date_of_event":"2018","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":17000000,"structured_issues":["Investment","Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Investment  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"7E34xcQYj7xEwtEeLopAISPjvre2dyXNhk536Y4O2nLyvXygDemnX4","news_summary":"https://www.jpost.com/Jpost-Tech/Biotechnology-General-opens-production-line-to-boost-manufacturing-capacity-603348","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"b3ca49a2-480f-4d5f-949d-18acd9b0051e","date":"Aug 9, 2018","link":"https://www.timesofisrael.com/biotech-firm-in-israel-makes-fertility-waves-with-genetically-modified-hormone/","source":"www.timesofisrael.com","visible":1,"analysis":{"tags":"fertility treatment","company":"Bio-Technology General (Israel) Ltd. (BTG)","layoffs":null,"summary":"Israeli biotech firm BTG has developed a new-generation fertility treatment called Rekovelle, which is a personalized hormone therapy that boosts the chances of patients seeking to get pregnant. The medication was launched by Swiss multinational pharmaceutical company Ferring, which acquired BTG in 2005. BTG genetically engineers human cell cultures to produce follicle stimulating hormone (FSH), which is used in in-vitro fertilization treatments. Ferring plans to expand production capabilities of the drug to meet market demand. BTG also develops and manufactures other medications using biological methods. The company hopes to create an ecosystem for biotech companies to thrive in Israel and become a hub for research, development, and manufacturing in the biotech industry.","partners":["Ferring"],"customers":null,"investors":null,"confidence":8,"key_topics":["fertility treatment","genetic engineering","manufacturing","biotech industry","personalized medicine"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$15 million","structured_issues":["Expand"],"acquisition_amount":null,"structuredIssuesShow":"#Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"0bCNqe60jgEfPZS6nw8WCy120kZntQmbWtagF2ObFlX2kDjnN20eGS","news_summary":"Biotech firm in Israel makes fertility waves with genetically modified hormone","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"2f86ab68-e9f9-4d3d-9034-a9f455663992","date":"May 23, 2018","link":"http://www.globes.co.il/en/article-ferring-invests-15m-in-israeli-unit-bio-technology-general-1001237498","source":"www.globes.co.il","visible":1,"analysis":{"tags":"expansion","company":"Ferring Pharmaceuticals","layoffs":null,"summary":"Ferring Pharmaceuticals is investing $15 million to expand biotech production capabilities at its Israeli subsidiary Bio-Technology General (BTG). The investment will support the development of new treatments in reproductive medicine and women’s health, as well as the manufacturing of the active pharmaceutical ingredient (API) for Ferrings latest fertility treatment, Rekovelle. The expansion will allow Ferring to maintain its scientific leadership in the fertility field and create innovative solutions for patients. BTG, founded in 1980, is the longest-standing bio-pharmaceutical company in Israel and employs around 300 people in its plant in Beer Tuvia Industrial Park.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["biotech production","reproductive medicine","womens health","fertility treatment","BTG facility"],"date_of_event":"May 23, 2018","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$15 million","structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"Oaa8ukDUlwhbCKBaBb6uDWd4ZutX8H186jR6cIoRPHjBVAXcbCpIej","news_summary":"Ferring invests $15m in Israeli unit Bio-Technology General","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"009e32b1-7496-46d5-9750-ea417ae0c323","date":"Jul 19, 2005","link":"https://www.ferring.com/en/media/press-releases/btg/","source":"www.ferring.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"5QjlVAPdfxx7TlK0Z2IoBWD4KJaP3llzgKNFA5AP6JWFvMy1ixHjCh","news_summary":"https://www.ferring.com/en/media/press-releases/btg/","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":6,"techcommunityinvolvement":null,"mediagallery":[],"tags":["eye-diseases","ophthalmology","genetic-engineering","osteoarthritis","biotechnology","biopharmaceutical","patients","pharma-companies"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA"],"technologysuccessstory":null,"usecases":[],"businessmodels":["B2B2C"],"productstage":"Released","products":["Somatropin","EUFLEXXA","Biolon"],"geomarkets":["Asia","Canada","Japan","United States","Australia","Europe","South America"],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":1,"lastfunding":"$15M","totalrounds":4,"fundingstage":"Acquired","totalfunding":"$26.93M","publicinvestors":1,"lastpublicfunding":15000000,"totalpublicrounds":4,"totalpublicfunding":26930000},"team":[{"name":"Ron Asafrana","email":"ron.asafrana@btgil.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4OrGqJgLDA","bounced":false,"claimed":0,"founder":0,"urlname":"ron-asafrana","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDg2sDwzAgM","position":"CFO","last_name":"Asafrana","claimtoken":"H6DsXdocLl2sKOqhSKICJdrsFwz3aF0nvu5ldGljijNM26NpdwpT8P","first_name":"Ron","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/ron-asafrana-48031b24/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2024-05-09 20:36:32.000000","initials":"RA","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Efrat  Horowitz Sivan","email":"efrat.sivan@btgil.com","phone":"","gender":"Female","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoJuCtKkIDA","bounced":false,"claimed":0,"founder":0,"urlname":"efrat-horowitz-sivan","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICg-670wAgM","position":"HR Director","last_name":"Horowitz Sivan","claimtoken":"fKKGeThwAFV8L8fwvooiEASSTUzyc3Ds7ewRjJU2qbJKYAI4pdHxo1","first_name":"Efrat ","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/efrat-horowitz-sivan-b7640915/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2024-05-09 20:36:28.000000","initials":"EH","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Tal Levi","email":"tal.levy@btgio.com","phone":"","gender":"Male","userid":"lqyjhk43GZdLdC0hUOgVwF9Xw93zcfURjYkc1RFMT9zplfiUCtIknM","bounced":false,"claimed":null,"founder":0,"urlname":"tal-levi-4","visible":1,"memberid":"AWJz8YkzUC6mXpSYxwFX26lJq2NR842hcsb5RiLIJRxuXPR38SpEAi","position":"General Manager","last_name":"Levi","claimtoken":"vaQg9P9SB903yQ40YjWU9psjWtXpfOOAulqgy2UxhFY4xH8vT6wksW","first_name":"Tal","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/tal-levy-62bb0078/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2024-05-09 20:36:30.000000","initials":"TL","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Dror Peretz","email":"dror.peretz@btgil.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4KrduZYKDA","bounced":false,"claimed":0,"founder":0,"urlname":"dror-peretz","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDg2vyHjgkM","position":"Operational Excellence","last_name":"Peretz","claimtoken":"GGjjRcDh9sj4fAheorllplmXOrTGPb8olM9gCNBocBVlir0NnTOHvK","first_name":"Dror","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/dror-peretz-a912763/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2024-05-09 20:36:25.000000","initials":"DP","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Pharmaceuticals","sectorverify":null,"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgPGylJ0IDA","fullname":"Natalia Golczar"},"biverifydate":"2019-11-13T00:00:00.000Z","crunchbaseid":"biotechnology-general","lastupdator":"Matan Eblagon","lastupdator_email":"matane@sncentral.org","creator":null,"creator_email":null,"createdate":"2014-10-06T00:00:00.000Z","biverification":"Natalia Golczar","sectorverification":null,"affiliatedOrganizations":[{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwIrN2pwKDA","name":"Ferring Pharmaceuticals","type":"Multinational","hidden":false,"fullurl":"/mnc_page/ferring-pharmaceuticals","logokey":"$P8C2psQeuYC2QBOslX9XrE3ycx16htRV90zBuyeUuZUMEwdYTGANdS","logourl":"https://storage.googleapis.com/clean-finder-353810/$P8C2psQeuYC2QBOslX9XrE3ycx16htRV90zBuyeUuZUMEwdYTGANdS","onClick":"","visibilityClassName":"","visibilityTooltip":""}],"timeline":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCEvIHoCAw","date":"May 2018","amount":"$15M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Ferring Pharmaceuticals","type":"Multinational","amount":0,"hidden":false,"country":"Switzerland","fullurl":"/mnc_page/ferring-pharmaceuticals","logokey":"$P8C2psQeuYC2QBOslX9XrE3ycx16htRV90zBuyeUuZUMEwdYTGANdS","tagline":"Pharmaceuticals","urlname":"/mnc_page/ferring-pharmaceuticals","isisraeli":null,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwIrN2pwKDA","fundingtype":"Multinational","leadpartner":null,"investmentid":"f6c3ecf6-30c8-4e04-9b7f-44c373fb929f","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$P8C2psQeuYC2QBOslX9XrE3ycx16htRV90zBuyeUuZUMEwdYTGANdS","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":15000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODkwNazCgw","date":"Feb 2016","amount":"$4.07M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":4070000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCEjdOICQw","date":"Jun 2015","amount":"$3.85M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":3850000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCkifP1CQw","date":"Jan 2015","amount":"$4.01M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":4010000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODEtfqECQw","date":"Jan 2005","amount":"Undisclosed","source":"Migrated","mnatype":"Acquisition","eventtype":"MNAEvent","investment":[],"wasacquired":1,"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"acquiredcompany_mna":"Ferring Pharmaceuticals","acquiredcompany_mna_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwIrN2pwKDA","acquiredcompany_mna_type":"Multinational","acquiredcompany_mna_hidden":false,"acquiredcompany_mna_fullurl":"/mnc_page/ferring-pharmaceuticals","acquiredcompany_mna_logokey":"$P8C2psQeuYC2QBOslX9XrE3ycx16htRV90zBuyeUuZUMEwdYTGANdS","acquiredcompany_mna_urlname":"/mnc_page/ferring-pharmaceuticals","acquiredcompany_mna_homepage":"http://www.ferring.com/en/home/","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","acquiredcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$P8C2psQeuYC2QBOslX9XrE3ycx16htRV90zBuyeUuZUMEwdYTGANdS","exit_label":"EXIT","po_label":"Initial Public Offering","acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":0,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"9/1980","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"BTG","logourl":"https://storage.googleapis.com/clean-finder-353810/$z9OMjnaNOrlNYAgvJuOia25w4MpmHXqjhXNma3J7hQvODZ9xl7qBle.jpeg","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$z9OMjnaNOrlNYAgvJuOia25w4MpmHXqjhXNma3J7hQvODZ9xl7qBle.jpeg","seoabout":"Bio-Technology General Israel (BTG) is an integrated biopharmaceutical services company that develops and manufactures healthcare products derived from gen...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":4,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drugs Discovery & Development","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Biologicals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Biotechnology","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Patients","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","classificationName":"targetcustomer"}],"classificationDelimited":["SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA>Drugs Discovery & Development#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA>Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA>Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Patients#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA"],"classificationsViewModel":"|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA/Drugs Discovery & Development#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA/Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA/Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Patients#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Pharma & Medical Biotechnology","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology","children":[{"title":"Drugs Discovery & Development","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology>Drugs Discovery & Development"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Life Sciences","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences","children":[{"title":"Biotechnology","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences>Biotechnology"},{"title":"Pharmaceuticals","key":"0-0-0-1","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences>Pharmaceuticals"}]},{"title":"Healthcare","key":"0-0-1","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare","children":[{"title":"Patients","key":"0-0-1-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Patients"}]}]}],"coreTechnology":[{"title":"Biologicals","key":"0-0","path":"TechnologyClassificationModel>Biologicals"}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drugs Discovery & Development","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Biologicals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Biotechnology","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Patients","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Pharma & Medical Biotechnology","Drugs Discovery & Development"],"coreTechnology":["Biologicals"],"targetCustomer":["Healthcare & Life Sciences","Life Sciences","Biotechnology","Pharmaceuticals","Healthcare","Patients"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"none","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODEtfqECQw","date":"Jan 2005","amount":"Undisclosed","source":"Migrated","mnatype":"Acquisition","eventtype":"MNAEvent","investment":[],"wasacquired":1,"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"acquiredcompany_mna":"Ferring Pharmaceuticals","acquiredcompany_mna_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwIrN2pwKDA","acquiredcompany_mna_type":"Multinational","acquiredcompany_mna_hidden":false,"acquiredcompany_mna_fullurl":"/mnc_page/ferring-pharmaceuticals","acquiredcompany_mna_logokey":"$P8C2psQeuYC2QBOslX9XrE3ycx16htRV90zBuyeUuZUMEwdYTGANdS","acquiredcompany_mna_urlname":"/mnc_page/ferring-pharmaceuticals","acquiredcompany_mna_homepage":"http://www.ferring.com/en/home/","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","acquiredcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$P8C2psQeuYC2QBOslX9XrE3ycx16htRV90zBuyeUuZUMEwdYTGANdS","exit_label":"EXIT","po_label":"Initial Public Offering","acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":0,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"privateequityfunding":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCEvIHoCAw","date":"May 2018","amount":"$15M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Ferring Pharmaceuticals","type":"Multinational","amount":0,"hidden":false,"country":"Switzerland","fullurl":"/mnc_page/ferring-pharmaceuticals","logokey":"$P8C2psQeuYC2QBOslX9XrE3ycx16htRV90zBuyeUuZUMEwdYTGANdS","tagline":"Pharmaceuticals","urlname":"/mnc_page/ferring-pharmaceuticals","isisraeli":null,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwIrN2pwKDA","fundingtype":"Multinational","leadpartner":null,"investmentid":"f6c3ecf6-30c8-4e04-9b7f-44c373fb929f","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$P8C2psQeuYC2QBOslX9XrE3ycx16htRV90zBuyeUuZUMEwdYTGANdS","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":15000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODkwNazCgw","date":"Feb 2016","amount":"$4.07M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":4070000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCEjdOICQw","date":"Jun 2015","amount":"$3.85M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":3850000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCkifP1CQw","date":"Jan 2015","amount":"$4.01M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":4010000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}